INTENSITY THERAPEUTICS INC (INTS)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$4.10+2.50%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · INTS
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | |
|---|---|---|---|---|---|---|
| Operating Expenses & Income | ||||||
| R&D Expenses | 6.1 | 6.8 | 10.5 | 4.8 | 5.1 | — |
| Operating Income | (11.5) | (12.0) | (16.6) | (8.3) | (7.6) | — |
| Earnings from Continuing Operations | ||||||
| Interest Expense | — | — | — | 0.3 | 0.1 | — |
| Interest & Investment Income | 0.3 | 0.2 | 0.3 | 0.3 | 0.0 | — |
| Net Interest Expenses | — | — | — | (0.0) | 0.1 | — |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | — |
| Net Income | ||||||
| Net Income | (11.2) | (11.6) | (16.3) | (10.5) | (7.6) | — |
| Per Share | ||||||
| Basic EPS | (4.12) | (8.56) | (1.17) | (1.38) | (2.22) | — |
| Diluted EPS | (4.12) | (8.56) | (1.17) | (1.38) | (2.22) | — |
| Basic Weighted Avg Shares | 2.7 | 1.4 | 13.9 | 8.6 | 3.4 | — |
| Diluted Weighted Avg Shares | 2.7 | 1.4 | 13.9 | 8.6 | 3.4 | — |
| Supplemental | ||||||
| EBIT | (11.5) | (12.0) | (16.6) | (8.3) | (7.6) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.